World Journal of Urology

, Volume 26, Issue 3, pp 251–256 | Cite as

Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers

  • M. J. Mathers
  • J. Zumbe
  • S. Wyler
  • S. Roth
  • M. Gerken
  • F. Hofstädter
  • T. Klotz
Original Article



Follow-up after cancer treatment has been focussing on the detection of local recurrence or metastatic disease of the primary cancer. Subsequent independent malignancies arising during follow-up have not been considered as relevant. Our study evaluated the risk of independent cancers following the diagnosis of primary urological cancer.

Materials and methods

From 1990 to 1998 data from 4,119 patients with a minimum follow-up of 5 years were collected. A total of 1,835 patients had primary prostate cancer, 1,269 and 1,015 patients had primary bladder and renal cell cancer, respectively. The most common subsequent malignancies in males were prostate cancer followed by lung and colon cancer. Breast and colon cancer were the most frequently detected subsequent cancers in females. The age correlated comparison of diagnosed and expected cancer in men with primary prostate cancer revealed an increase in relative risk for bladder, kidney and rectal cancer of 3.75, 2.03 and 1.32-fold, respectively. In men with primary bladder cancer the relation for prostate, kidney and lung cancer was 4.05, 2.51 and 2.13-fold, respectively; for females the relation for kidney cancer was 4.55-fold. In men with primary kidney cancer subsequent rectal, prostate and bladder cancer showed a 4.38, 2.91 and 2.48-fold increase, respectively.


These data suggest an increase in relative risk for subsequent urologic and non-urologic cancer during follow-up. Clinicians involved in oncological follow-up need to be aware of this finding. To which degree a follow-up scheme, not solely focussing on the primary urological malignancy could improve survival needs to be evaluated in further studies.


Prostate cancer Bladder cancer Renal cell cancer Follow-up Subsequent malignancies Second primary neoplasms Cancer incidence 


  1. 1.
    Arbeitsgemeinschaft bevölkerungsbezogener Krebsregister (2004) Krebs in Deutschland 4, Auflage, SaarbrückenGoogle Scholar
  2. 2.
    Bittorf B, Kessler H, Merkel S, Bruckl W, Wein A, Ballhausen WG, Hohenberger W, Gunther K (2001) Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol 27:302–313PubMedCrossRefGoogle Scholar
  3. 3.
    National Cancer Institutes. Cancer trends progress report—2005 UpdatesGoogle Scholar
  4. 4.
    Jensen OM, Knudsen JB, Sorensen BL (1985) Second cancer following cancer of the urinary system in Denmark, 1943–1980. Natl Cancer Inst Monogr 68:349–360PubMedGoogle Scholar
  5. 5.
    Klotz T, Hofstadter F, Gerken M (2003) Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma. Urologe A 42:1485–1490PubMedCrossRefGoogle Scholar
  6. 6.
    McCredie M, Macfarlane GJ, Stewart J, Coates M (1996) Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972–1991. Cancer Causes Control 7:337–344PubMedCrossRefGoogle Scholar
  7. 7.
    Merimsky O, Kollender Y, Issakov J, Bickels J, Flusser G, Gutman M, Lev-Chelouche D, Inbar M, Meller I (2001) Multiple primary malignancies in association with soft tissue sarcomas. Cancer 91:1363–1371PubMedCrossRefGoogle Scholar
  8. 8.
    Rabbani F, Grimaldi G, Russo P (1998) Multiple primary malignancies in renal cell carcinoma. J Urol 160:1255–1259PubMedCrossRefGoogle Scholar
  9. 9.
    Salminen E, Pukkala E, Teppo L (1994) Bladder cancer and the risk of smoking-related cancers during followup. J Urol 152:1420–1423PubMedGoogle Scholar
  10. 10.
    Salminen E, Pukkala E, Teppo L, Pyrhonen S (1994) Subsequent primary cancers following bladder cancer. Eur J Cancer 30A:303–307PubMedCrossRefGoogle Scholar
  11. 11.
    Takahashi S, Sugimoto M, Shinohara M, Kinoshita K (1992) Clinical analysis of multiple primary cancers associated with bladder cancer. Nippon Hinyokika Gakkai Zasshi 83:1118–1123PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • M. J. Mathers
    • 1
    • 6
  • J. Zumbe
    • 2
  • S. Wyler
    • 2
  • S. Roth
    • 3
  • M. Gerken
    • 4
  • F. Hofstädter
    • 4
  • T. Klotz
    • 5
  1. 1.Urological Ambulatory (in cooperation with the Department of Urology, Klinikum Wuppertal, University of Witten/Herdecke)RemscheidGermany
  2. 2.Department of UrologyKlinikum LeverkusenLeverkusenGermany
  3. 3.Department of UrologyKlinikum Wuppertal, University of Witten/HerdeckeWuppertalGermany
  4. 4.TumourcenterRegensburgGermany
  5. 5.Department of UrologyKlinikum WeidenWeidenGermany
  6. 6.RemscheidGermany

Personalised recommendations